Cargando…
Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats
Oxaliplatin, a widely used chemotherapeutic agent, induces peripheral neuropathy that manifests itself as two distinct phases: acute cold hyperesthesia and chronic peripheral hypoesthesia/dysesthesia. The latter is a serious dose-limiting side effect that can often lead to withdrawal of treatment. W...
Autores principales: | Kono, Toru, Suzuki, Yasuyuki, Mizuno, Keita, Miyagi, Chika, Omiya, Yuji, Sekine, Hitomi, Mizuhara, Yasuharu, Miyano, Kanako, Kase, Yoshio, Uezono, Yasuhito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635352/ https://www.ncbi.nlm.nih.gov/pubmed/26542342 http://dx.doi.org/10.1038/srep16078 |
Ejemplares similares
-
An effective therapeutic approach for oxaliplatin-induced peripheral neuropathy using a combination therapy with goshajinkigan and bushi
por: Mizuno, Keita, et al.
Publicado: (2016) -
Ignavine: a novel allosteric modulator of the μ opioid receptor
por: Ohbuchi, Katsuya, et al.
Publicado: (2016) -
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
por: Kono, Toru, et al.
Publicado: (2013) -
Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer
por: Kono, Toru, et al.
Publicado: (2011) -
Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients
por: Yoshida, Naohisa, et al.
Publicado: (2013)